U.S. Retail Distributors Stock News

Arrowhead Pharmaceuticals recently appointed Dr. Matt Cohen, a healthcare investor with more than 25 years of sector experience and a medical background, to its board of directors, and announced a 2026 Summer Series of R&D webinars highlighting its TRiM-based RNAi pipeline, including a cardiometabolic-focused session on June 29, 2026. By adding an experienced institutional healthcare investor to the board while spotlighting late-stage RNAi programs through dedicated R&D events, Arrowhead is...

TRIDENT trial outcome and what it means for NovoCure stock NovoCure (NVCR) shares are reacting to topline data from the Phase 3 TRIDENT trial, where starting Tumor Treating Fields therapy during chemoradiation did not improve overall survival versus starting in the maintenance phase. For investors watching NovoCure stock, the result keeps attention on how the company uses these data to refine the clinical positioning of TTFields in glioblastoma while maintaining the reported safety and...

Rising tariff swings and fast supply chain changes are turning compliance and risk management from a back-office task into a front-line issue for investors. As companies rush to rework suppliers and shipping routes, the pressure around sanctions screening, export controls, and documentation is climbing. That is putting more attention on stocks tied to compliance and risk technology, where stronger tools can help businesses stay on the right side of regulators and protect margins. This article...

AutoZone (AZO) has drawn investor attention after recent share price pressure, with the stock down about 9% over the past month and roughly 8% over the past 3 months. See our latest analysis for AutoZone. At a latest share price of $3,059.63, AutoZone’s recent 1 month share price return of down 9.1% and year to date share price return of down 7.4% contrast with a 5 year total shareholder return of 112%, suggesting momentum has faded after a strong longer term run. If you are assessing where...

Advanced Micro Devices (NasdaqGS:AMD) has agreed to acquire MEXT, a company focused on software-driven memory optimization for AI data centers and inference workloads. AMD has also entered a multi-year partnership with Rackspace to provide governed enterprise AI infrastructure for regulated industries. These moves expand AMD's role in AI data centers beyond chips, adding software capabilities and long-term infrastructure delivery. Advanced Micro Devices is adding fresh layers to its AI...

Neogen Corporation recently expanded the availability of FIFRA Section 2(ee) recommendations for its Prozap Insectrin X Concentrate and Prozap Screw Worm and Ear Tick Aerosol in Texas and Florida, giving livestock and horse owners more options to support New World Screwworm and fly management efforts beyond standard EPA label uses. This move strengthens Neogen’s role in specialized animal safety and pest control programs, potentially reinforcing demand for its Prozap portfolio within broader...

With oil prices reacting to an interim US Iran peace deal, tech stocks lifting major indexes, and the Federal Reserve keeping a firm tone on interest rates, large cap U.S. dividend stocks sit at an important crossroads. Some companies could benefit from cheaper energy and stronger risk appetite, while others may feel pressure from higher funding costs and stubborn inflation. This article focuses on three stocks from the Large Cap U.S. Dividend Stocks screener that appear closely exposed to...

Earlier this month, JFrog announced a new JFrog Platform plugin for Anthropic’s Claude Code, giving enterprises governed, supply-chain-aware AI coding agents with integrated security, compliance, and traceability features. By embedding policy enforcement and provenance checks directly into AI-assisted development workflows, the collaboration aims to curb unorthodox agent behavior while streamlining DevOps and strengthening audit readiness. Next, we’ll explore how this Claude Code...

Earlier this year, Global Travel Retail Holdings’ Starboard announced a collaboration with Carnival Cruise Line and Diageo to offer a limited-edition, single-barrel Bulleit Bourbon, priced at US$59.99 and sold exclusively in retail stores across 14 Carnival ships as part of America’s 250th anniversary celebrations. This partnership highlights how Carnival is using exclusive onboard products and branded experiences to deepen guest engagement and enhance higher-margin retail spending at...

Trulieve Cannabis recently became the first U.S. cannabis company to list on the New York Stock Exchange after restructuring to separate its federally compliant medical operations from its adult-use business. This step, combined with a newly authorized share repurchase program of up to US$50,000,000 or 8,495,038 shares, could broaden institutional access and reshape how investors view Trulieve’s capital allocation priorities. Now we’ll explore how Trulieve’s NYSE listing and new buyback...

CME Group (CME) stock is in focus after the company confirmed a leadership transition that will see long time Chairman and CEO Terry Duffy move to Executive Chairman while President and CFO Lynne Fitzpatrick becomes CEO in 2027. See our latest analysis for CME Group. The leadership announcement landed against a weaker backdrop for CME Group stock, with the share price down 3.46% over the past day and 17.23% over the past 30 days, while the 5 year total shareholder return of 45.07% still...

Asbury Automotive Group (ABG) stock has moved without a clear single event driving trading. This puts more attention on its fundamentals, recent share performance, and how investors might interpret the current valuation. See our latest analysis for Asbury Automotive Group. At a share price of $190.13, Asbury Automotive Group’s recent 1 day share price decline of 4.85% and 7 day decline of 4.04% contrast with a 30 day share price return of 7.86%, while the 1 year total shareholder return is...

Match Group (MTCH) stock drew fresh attention after a new peace deal across Asia-Pacific and the Middle East reduced operational risks, supported advertiser confidence, and coincided with lower oil prices and bond yields. See our latest analysis for Match Group. At a share price of $35.31, Match Group has seen a 90 day share price return of 12.2%, while the 1 year total shareholder return of 19.3% contrasts with a weaker 3 and 5 year record. This suggests recent momentum has picked up after a...

Silicon Laboratories (SLAB) is drawing attention after recent returns and fundamentals highlighted a mixed picture, including annual revenue of $820.55 million alongside a reported net loss of $50.334 million for the period. See our latest analysis for Silicon Laboratories. At a share price of $218.61, Silicon Laboratories has had a mixed short term run. The 90 day share price return of 6.23% and year to date share price return of 65.70% sit alongside a 1 year total shareholder return of...

Recent data show that Merchants Bancorp has seen a very large quarter-over-quarter jump in institutional ownership, alongside year-over-year increases in quarterly revenue and net profit, even as some financial health metrics remain weak. This combination of higher institutional participation and improving profitability, despite operating efficiency concerns, gives investors a more nuanced view of the bank’s risk‑reward profile. Next, we’ll examine how the surge in institutional ownership...

The sudden reopening of the Strait of Hormuz after a diplomatic deal between the United States, Iran and Saudi Arabia has put global shipping and marine transport stocks back in the spotlight. With three Saudi supertankers quietly reappearing on radar and 6 million barrels now moving through this vital chokepoint, investors are reassessing which companies might benefit if oil flows become more regular and freight activity gradually normalises. This article highlights 3 stocks from the Global...

Earlier this year, CorVel Corporation launched CorVel Marketwise Repricing™, a market-based medical bill repricing solution designed to enhance cost containment and integrate into existing bill review workflows, particularly for out-of-network bills and jurisdictions without robust fee schedules. The product’s emphasis on aligning reimbursements with local market conditions and capturing savings beyond traditional methods could be important for payers seeking more predictable medical cost...

Science Applications International (SAIC) drew fresh attention after recent trading left the stock around $106.73, with mixed short term returns in contrast to gains over the past month and past three months. See our latest analysis for Science Applications International. Over a longer window, Science Applications International’s share price return has been steadier than the recent pullback, with the stock posting gains over the past month, quarter and year to date, while the 1 year total...

With the Federal Reserve holding rates at 3.5%–3.75% and signaling that borrowing costs may stay restrictive for longer, some financial stocks look more closely tied to this higher rate backdrop than others. This article uses a targeted screener to highlight three large banking and insurance stocks that appear especially exposed to the latest Fed news, whether through lending margins, underwriting income, or balance sheet positioning. You will see how each stock lines up against a higher for...

Recent trading in Delek US Holdings (DK) has drawn attention after the stock ended the latest session at $42.34, with moves over the past week and month showing declines alongside strong year to date and 1 year total returns. See our latest analysis for Delek US Holdings. The recent pullback, including a 3.88% one day share price decline and weaker 7 day and 30 day share price returns, contrasts with Delek US Holdings' much stronger 1 year and multi year total shareholder returns. This...

At the EAACI 2026 congress in Istanbul, Pharvaris reported Phase 3 RAPIDe-3 data showing rapid, sustained efficacy and favorable safety for its oral deucrictibant capsule in treating hereditary angioedema attacks, alongside supportive long-term prophylaxis and cardiovascular safety findings. A distinctive feature of the update was the introduction of the End of Progression™ endpoint, highlighting how quickly deucrictibant can halt worsening symptoms and potentially improve patients’...

In its latest reported quarter, Green Plains Inc. posted a 25.89% year-over-year revenue decline and a very large year-over-year drop in net profit, while still ranking 6th out of 29 peers for financial health in the Renewable Energy industry. This combination of weaker quarterly performance and relatively strong balance sheet positioning creates a mixed picture that may influence how investors weigh Green Plains' transition plans and risk profile. Now we’ll consider how this steep quarterly...

Hut 8 (HUT) is drawing fresh attention after a series of AI focused moves, including large investment grade project financing, long term data center leases, and the appointment of E. Stanley O’Neal as board chair. See our latest analysis for Hut 8. Against that backdrop of board changes, large bond financing and long term AI data center leases, Hut 8’s 1 day share price return declined 2.14% to $118.88. Its 90 day share price return of 137.10% and very large 1 year total shareholder return...

Recently, Bio-Rad Laboratories reported year-over-year growth in both revenue and net profit while institutional investors, led by First Eagle Investment, significantly reduced their holdings and technical indicators leaned toward selling. This contrast between strengthening financial results and declining institutional ownership, alongside neutral-to-weak technical signals, raises fresh questions about how different investor groups are interpreting Bio-Rad’s underlying business...